Table.

Hazard ratios in study cohorts with idiopathic pulmonary fibrosis for GAP index and monocytes

	Hazard ratio	95% CI	p value
COMET (n=36)
GAP index	1·42	0·77–2·63	0·26
Monocytes	2·65	0·95–7·34	0·060
Monocytes (age and sex corrected)	2·46	0·86–6·98	0·092
Monocytes (FVC-corrected)	2·69	0·97–7·45	0·057
Monocytes (GAP-corrected)	2·64	0·95–7·33	0·062
Stanford (n=130)
GAP index	1·73	1·34–2·25	<0·0001
Monocytes	2·83	1·17–6·81	0·026
Monocytes (age and sex corrected)	2·30	0·94–5·63	0·067
Monocytes (FVC-corrected)	2·43	1·00–5·91	0·049
Monocytes (GAP-corrected)	1·87	0·76–4·61	0·17
Vanderbilt (n=1607)
Monocytes	1·46	1·17–1·82	0·00094
Monocytes (age and sex corrected)	1·52	1·21–1·89	<0·0001
Optum (n=5722)
Monocytes	1·96	1·50–2·56	<0·0001
Monocytes (age and sex corrected)	1·74	1·33–2·27	<0·0001
Northwestern (n=365)
GAP index	1·65	1·35–2·02	<0·0001
Monocytes	2·25	1·01–5·04	0·049
Monocytes (age and sex corrected)	2·06	0·91–4·69	0·082
Monocytes (FVC-corrected)	2·39	1·06–5·38	0·035
Monocytes (GAP-corrected)	1·90	0·83–4·36	0·13

Data are shown with and without correction for age, sex, predicted forced vital capacity (FVC), and GAP (gender, age, and physiology index).